✦ LIBER ✦

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

✍ Scribed by Saltz, L. B.; Clarke, S.; Diaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T.-S.; Rivera, F.; Couture, F.; Sirzen, F.; Cassidy, J.

Book ID: 126231421
Publisher: American Society of Clinical Oncology
Year: 2008
Tongue: English
Weight: 157 KB
Volume: 26
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2007.14.9930

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in Combination With Chemothe

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

✍ Ohtsu, A.; Shah, M. A.; Van Cutsem, E.; Rha, S. Y.; Sawaki, A.; Park, S. R.; Lim 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 203 KB

A phase ΙI study of five peptides combin

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

✍ Hazama, Shoichi; Nakamura, Yusuke; Tanaka, Hiroaki; Hirakawa, Kosei; Tahara, Ko; 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 431 KB

Axitinib and/or bevacizumab with modifie

Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study

✍ Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cesco 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

An observational study of bevacizumab co

An observational study of bevacizumab combined with FOLFIRI as the first-line treatment in metastatic colorectal cancer

✍ Huang, Meng-Lin; Kan, Jung-Yu; Ma, Cheng-Jen; Huang, Ching-Wen; Chen, Fang-Ming; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 261 KB

Front-line Bevacizumab in combination wi

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

Multicenter phase II study of second-lin

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy

✍ Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh P 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB